molecular harvesting platform

ANGLE’s patented Parsortix system can harvest very rare CTCs in cancer patient blood – even when there is less than one CTC in one billion healthy cells.  The resulting liquid biopsy (simple blood test) enables the investigation of mutations in the patient’s cancer for personalised cancer care.  The Parsortix system is “open-source” and has been designed to work with all existing analytical procedures in the same way that the existing solid biopsy provides cancer cells for a wide variety of analytical procedures.

Read More »